Acne: Asthma Drug Fails to Help Patients with Acne


Acne : Acne: Asthma Drug Fails to Help Patients with Acne	Homepage \| Add to Favorites

Recommended Sites

Related Links

Informative Articles

Acne Solution From a Pill
Most people believe the only way to cure their acne problem is from the outside. Well, you definitely need to keep your skin clean, but often, acne sufferers scrub too hard or use harsh chemicals to try to clean deep. This can actually make...

Girls, Puberty and Acne
How Acne affects young girls in puberty. Girls go through many physical and psychological changes during puberty. These changes include body composition, fat distribution, menstruation, growth spurts, body and facial hair growth, body odor and...

Natural Skin Care - Just Open Your Kitchen Cabinet
Safer, less expensive, and easy-to-use natural skin care can be as easy as opening your kitchen cabinet, coupled with a few minutes of preparation. Healthy, radiant, glowing skin is something every person wants. Yet, few of us even think to use...

The Truth About Acne Skin Care
Let's face it, you are engaged in an ongoing battle when you are afflicted with acne. While acne treatments for a mild case of acne are usually successful, moderate acne is a greater problem. Even dermatologists cannot cure a severe case of acne but...

Using the Best Skin Peel at Home
In the past, the best skin peel was only available from a dermatologist or salon. This is no longer true. You can now have the benefits of a medical grade facial peel in the comfort of your own home. The most effective peels on the market...

Acne: Asthma Drug Fails to Help Patients with Acne

The asthma drug Zyflo fails to help patients with severe acne, according to a mid-stage trial carried out by the company Critical Therapeutics Inc. The drug, also known as zileuton, was neither better at controlling the number of inflammatory lesions than placebos under the company statistics.

Over the 12-week trial, patients treated with Zyflo had an average reduction of 11.5 inflammatory lesions. That compared with a reduction of 9.1 lesions in a group of other patients taking placebos - far short of achieving statistical significance.

Patients treated with placebo showed a reduction of 16.4 lesions in the placebo group, but patients treated with Zyflo showed a mean reduction in the total number of lesions of 25.3.

The company stated the medicine showed a trend of potential benefit to some patients although the drug failed the primary goal of the trial.

Linda Lennox, the company spokeswoman, told the company will probably conduct a larger trial testing the medicine as an acne treatment, using information gleaned from the small recent "proof of concept" trial.

The company based in Lexington, Massachusetts, said that it is continuing to analyze the data and is working with the investigators to further interpret the results.

Zyflo blocks an inflammation-causing enzyme called 5 lipoxygenase (5-LO). It was approved by U.S. regulators in 1996 for treating asthma patients 12 years of age and older. At the time, the drug was owned by Abbott Laboratories Inc., which sold it for a number of years before licensing it to Critical Therapeutics in late 2003.

Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution products information . Thanks for use this article in your website or ezine keeping a live link.

About the author:

Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution pr